Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

BACKGROUND: The herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycoprotein E (gE) and AS01(B) Adjuvant System, was highly efficacious in preventing herpes zoster in the ZOE-50 and ZOE-70 trials. We present immunogenicity results from those trials. METHODS: Participants...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Cunningham, Anthony L, Heineman, Thomas C, Lal, Himal, Godeaux, Olivier, Chlibek, Roman, Hwang, Shinn-Jang, McElhaney, Janet E, Vesikari, Timo, Andrews, Charles, Choi, Won Suk, Esen, Meral, Ikematsu, Hideyuki, Choma, Martina Kovac, Pauksens, Karlis, Ravault, Stéphanie, Salaun, Bruno, Schwarz, Tino F, Smetana, Jan, Abeele, Carline Vanden, Van den Steen, Peter, Vastiau, Ilse, Weckx, Lily Yin, Levin, Myron J
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5946839/
https://ncbi.nlm.nih.gov/pubmed/29529222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiy095
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados